vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Turning Point Brands, Inc.（TPB）财务数据对比。点击上方公司名可切换其他公司
Turning Point Brands, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$121.0M vs $75.5M），Turning Point Brands, Inc.同比增速更快（29.2% vs 27.7%），Turning Point Brands, Inc.自由现金流更多（$21.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 20.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Turning Point Australia（TPAUS）是一家位于澳大利亚的保守派游说团体，隶属于美国转折点组织但保持独立运营，由乔尔·贾马尔创立并于2023年完成注册。该团体目前正积极行动，试图影响2026年3月举行的南澳大利亚州选举结果。
PBYI vs TPB — 直观对比
营收规模更大
TPB
是对方的1.6倍
$75.5M
营收增速更快
TPB
高出1.5%
27.7%
自由现金流更多
TPB
多$7.1M
$14.4M
两年增速更快
PBYI
近两年复合增速
20.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $121.0M |
| 净利润 | — | $8.2M |
| 毛利率 | 69.3% | 55.9% |
| 营业利润率 | 22.7% | 16.5% |
| 净利率 | — | 6.8% |
| 营收同比 | 27.7% | 29.2% |
| 净利润同比 | — | 239.8% |
| 每股收益（稀释后） | $0.26 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYITPB
| Q4 25 | $75.5M | $121.0M | ||
| Q3 25 | $54.5M | $119.0M | ||
| Q2 25 | $52.4M | $116.6M | ||
| Q1 25 | $46.0M | $106.4M | ||
| Q4 24 | $59.1M | $93.7M | ||
| Q3 24 | $80.5M | $90.7M | ||
| Q2 24 | $47.1M | $93.2M | ||
| Q1 24 | $43.8M | $83.1M |
净利润PBYITPB
| Q4 25 | — | $8.2M | ||
| Q3 25 | $8.8M | $21.1M | ||
| Q2 25 | $5.9M | $14.5M | ||
| Q1 25 | $3.0M | $14.4M | ||
| Q4 24 | — | $2.4M | ||
| Q3 24 | $20.3M | $12.4M | ||
| Q2 24 | $-4.5M | $13.0M | ||
| Q1 24 | $-4.8M | $12.0M |
毛利率PBYITPB
| Q4 25 | 69.3% | 55.9% | ||
| Q3 25 | 77.7% | 59.2% | ||
| Q2 25 | 76.5% | 57.1% | ||
| Q1 25 | 77.1% | 56.0% | ||
| Q4 24 | 76.4% | 56.0% | ||
| Q3 24 | 63.9% | 55.6% | ||
| Q2 24 | 77.4% | 54.1% | ||
| Q1 24 | 75.5% | 58.2% |
营业利润率PBYITPB
| Q4 25 | 22.7% | 16.5% | ||
| Q3 25 | 17.6% | 21.8% | ||
| Q2 25 | 12.7% | 22.6% | ||
| Q1 25 | 8.7% | 21.8% | ||
| Q4 24 | 22.6% | 19.1% | ||
| Q3 24 | 27.4% | 22.9% | ||
| Q2 24 | -4.6% | 24.5% | ||
| Q1 24 | -5.3% | 23.2% |
净利率PBYITPB
| Q4 25 | — | 6.8% | ||
| Q3 25 | 16.2% | 17.7% | ||
| Q2 25 | 11.2% | 12.4% | ||
| Q1 25 | 6.5% | 13.5% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 25.2% | 13.6% | ||
| Q2 24 | -9.6% | 14.0% | ||
| Q1 24 | -11.0% | 14.5% |
每股收益（稀释后）PBYITPB
| Q4 25 | $0.26 | $0.40 | ||
| Q3 25 | $0.17 | $1.13 | ||
| Q2 25 | $0.12 | $0.79 | ||
| Q1 25 | $0.06 | $0.79 | ||
| Q4 24 | $0.40 | $0.15 | ||
| Q3 24 | $0.41 | $0.68 | ||
| Q2 24 | $-0.09 | $0.68 | ||
| Q1 24 | $-0.10 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $222.8M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $372.0M |
| 总资产 | $216.3M | $763.8M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYITPB
| Q4 25 | $97.5M | $222.8M | ||
| Q3 25 | $94.4M | $201.2M | ||
| Q2 25 | $96.0M | $109.9M | ||
| Q1 25 | $93.2M | $99.6M | ||
| Q4 24 | $101.0M | $48.9M | ||
| Q3 24 | $96.7M | $33.6M | ||
| Q2 24 | $96.8M | $142.2M | ||
| Q1 24 | $107.2M | $130.9M |
总债务PBYITPB
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYITPB
| Q4 25 | $130.3M | $372.0M | ||
| Q3 25 | $115.3M | $358.2M | ||
| Q2 25 | $104.7M | $224.8M | ||
| Q1 25 | $97.1M | $203.4M | ||
| Q4 24 | $92.1M | $190.4M | ||
| Q3 24 | $71.1M | $185.7M | ||
| Q2 24 | $48.5M | $172.8M | ||
| Q1 24 | $51.0M | $160.0M |
总资产PBYITPB
| Q4 25 | $216.3M | $763.8M | ||
| Q3 25 | $202.9M | $742.8M | ||
| Q2 25 | $194.9M | $595.8M | ||
| Q1 25 | $196.2M | $564.6M | ||
| Q4 24 | $213.3M | $493.4M | ||
| Q3 24 | $220.7M | $488.0M | ||
| Q2 24 | $205.0M | $591.6M | ||
| Q1 24 | $214.1M | $586.3M |
负债/权益比PBYITPB
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $24.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $21.5M |
| 自由现金流率自由现金流/营收 | 19.1% | 17.8% |
| 资本支出强度资本支出/营收 | 0.0% | 2.8% |
| 现金转化率经营现金流/净利润 | — | 3.03× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $43.8M |
8季度趋势，按日历期对齐
经营现金流PBYITPB
| Q4 25 | $14.4M | $24.9M | ||
| Q3 25 | $9.7M | $3.3M | ||
| Q2 25 | $14.1M | $11.8M | ||
| Q1 25 | $3.6M | $17.4M | ||
| Q4 24 | $15.6M | $17.7M | ||
| Q3 24 | $11.0M | $13.2M | ||
| Q2 24 | $1.0M | $13.4M | ||
| Q1 24 | $11.2M | $22.6M |
自由现金流PBYITPB
| Q4 25 | $14.4M | $21.5M | ||
| Q3 25 | $9.7M | $-721.0K | ||
| Q2 25 | $14.1M | $7.8M | ||
| Q1 25 | $3.6M | $15.2M | ||
| Q4 24 | $15.6M | $16.6M | ||
| Q3 24 | $11.0M | $12.6M | ||
| Q2 24 | $1.0M | $10.9M | ||
| Q1 24 | — | $22.3M |
自由现金流率PBYITPB
| Q4 25 | 19.1% | 17.8% | ||
| Q3 25 | 17.7% | -0.6% | ||
| Q2 25 | 26.8% | 6.7% | ||
| Q1 25 | 7.7% | 14.3% | ||
| Q4 24 | 26.4% | 17.8% | ||
| Q3 24 | 13.7% | 13.9% | ||
| Q2 24 | 2.1% | 11.7% | ||
| Q1 24 | — | 26.8% |
资本支出强度PBYITPB
| Q4 25 | 0.0% | 2.8% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 0.0% | 3.4% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 2.7% | ||
| Q1 24 | 0.0% | 0.4% |
现金转化率PBYITPB
| Q4 25 | — | 3.03× | ||
| Q3 25 | 1.10× | 0.16× | ||
| Q2 25 | 2.41× | 0.82× | ||
| Q1 25 | 1.21× | 1.21× | ||
| Q4 24 | — | 7.34× | ||
| Q3 24 | 0.54× | 1.07× | ||
| Q2 24 | — | 1.03× | ||
| Q1 24 | — | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
TPB
| US | $111.5M | 92% |
| Non Us | $9.6M | 8% |
